Evidence map›Paper›PMID 30266839›Full record

ArticleDisease models & mechanisms2018

Modelling brain dopamine-serotonin vesicular transport disease in

Alexander T Young, Kien N Ly, Callum Wilson, Klaus Lehnert, Russell G Snell, Suzanne J Reid, Jessie C Jacobsen

Open access · goldAbstract read
In one paragraph

Article in Disease models & mechanisms, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Nicotine Motivated Behavior inInternational journal of molecular sciences · 2024
    Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Alexander T YoungThe School of Biological Sciences and Centre for Brain Research, The University of Auckland, Auckland 1010, New Zealand.
Kien N LyThe School of Biological Sciences and Centre for Brain Research, The University of Auckland, Auckland 1010, New Zealand kn.ly@auckland.ac.nz.ORCID 0000-0003-0741-6001
Callum WilsonAdult and Paediatric National Metabolic Service, Auckland City Hospital, Auckland 1023, New Zealand.ORCID 0000-0003-2034-767X
Klaus LehnertThe School of Biological Sciences and Centre for Brain Research, The University of Auckland, Auckland 1010, New Zealand.ORCID 0000-0003-4598-4966
Russell G SnellThe School of Biological Sciences and Centre for Brain Research, The University of Auckland, Auckland 1010, New Zealand.ORCID 0000-0002-8166-4014
Suzanne J ReidThe School of Biological Sciences and Centre for Brain Research, The University of Auckland, Auckland 1010, New Zealand.ORCID 0000-0002-8068-6529
Jessie C JacobsenThe School of Biological Sciences and Centre for Brain Research, The University of Auckland, Auckland 1010, New Zealand.
University of Auckland · NZAuckland City Hospital · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brain dopamine-serotonin vesicular transport disease is a rare disease caused by autosomal recessive mutations in the

Indexed as

Models, BiologicalAnimalsAnimals, Genetically ModifiedBase SequenceBiological TransportBrainCaenorhabditis elegansDopamineHumansPharynxPhenotypeSerotoninTransport VesiclesDopamineSerotoninAnimal modelCaenorhabditis elegansCat-1Dopamine-serotonin transport diseaseVMAT

Identifiers

PMID30266839
PMCPMC6262812
OpenAlexW2893685428

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.